تحميل...
Resistance is futile: overcoming resistance to targeted therapies in lung adenocarcinoma
The advent of genomics has led to the identification of specific “driver” mutations in oncogenic kinases, and the development of targeted small molecule inhibitors to block their tumor-driving functions. These specific inhibitors have been a clinical success, and often significantly prolong the live...
محفوظ في:
| الحاوية / القاعدة: | NPJ Precis Oncol |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Nature Publishing Group UK
2017
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5687582/ https://ncbi.nlm.nih.gov/pubmed/29152593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41698-017-0007-0 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|